Phase 4Completed
A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting
- Sponsor
- Supernus Pharmaceuticals, Inc. (Industry)
- Enrollment
- 52 enrolled
- Conditions
- Postpartum Depression
- Interventions
- ZULRESSO®
- Ages
- adults, older adults
- Registry
- NCT05059600
Full record on ClinicalTrials.gov
From the registry
The primary purpose of this study was to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting.
Primary outcomes
- Percentage of Participants With At Least One Treatment-Emergent Adverse Event (TEAE) Leading to Dose Interruption/Discontinuation
History
Last registry update
Results first posted
Primary completion
Started
Registered